在主导性帕金森病方面,不安腿综合征与亚thalamic深脑刺激有关
Lionel Tordjman1, Ouhaïd Lagha-Boukbiza2, Mathieu Anheim2
1CIRCSom (International Research Center for ChronoSomnology) & Sleep Disorders Center, University Hospital of Strasbourg, 1 Place de L'Hôpital, F-67000, Strasbourg, France.
Sleep medicine
|February 17, 2024
概括
不安腿综合征 (RLS) 在帕金森病 (PD) 患者的脑下深层刺激 (DBS-STN) 后可能发生. 禁用DBS-STN改善了RLS症状,这表明与多巴胺基基调有联系.
科学领域:
- 神经学 神经学
- 运动障碍 运动障碍
背景情况:
- 不安腿综合征 (RLS) 在帕金森病 (PD) 患者中更为常见.
- RLS症状可以模仿PD,使诊断在这个人群中变得复杂.
研究的目的:
- 报告一个PD患者在脑下深层刺激 (DBS-STN) 后出现新发性RLS病例.
- 通过使用建议固定化试验 (SIT) 调查DBS-STN对RLS症状的影响.
主要方法:
- 一名59岁的男性患有异常性PD接受了DBS-STN.
- 通过使用DBS-STN激活和禁用,使用1小时的SIT来评估RLS症状.
- 运动和RLS的感觉方面通过SIT和视觉模拟尺度进行了评估.
主要成果:
- 患者在DBS-STN后发展出残疾的RLS,其特点是休息时腿部不适,迫切需要移动和夜间恶化.
- 在禁用DBS-STN.之后,RLS症状消失了.
- 关闭DBS-STN也导致对侧手臂的震再次出现.
结论:
- 在PD患者中,DBS-STN可能会诱导或改善RLS,可能是通过超多巴胺基基调.
- 在DBS-STN之前和之后,SIT是评估PD患者RLS的潜在有价值的工具.
相关概念视频
Restless Leg Syndrome and Night Terrors
177
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
177
REM Sleep Behavior Disorder
184
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
184
Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
Parkinson's Disease: Overview
546
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
546
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K


